	Actif À Court Terme		Date
Agios Pharmaceuticals	USD 1.03B	13.64M	2025-09
ALKERMES	USD 1.74B	106.38M	2025-09
Alterity Therapeutics Limited	AUD 27.05M	6.16M	2023-06
Amgen	USD 29.06B	1.17B	2025-12
Baxter International	USD 6.93B	184M	2025-09
BioCryst Pharmaceuticals	USD 355.68M	42.78M	2025-09
Biogen	USD 8.97B	37.5M	2025-12
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Cara Therapeutics	USD 43.13M	4.18M	2025-06
Cipla	INR 249.18B	16.3B	2025-09
Dr.Reddys Laboratories	INR 297.55B	18.03B	2025-12
Eisai	JPY 840.88B	50.18B	2025-12
Eli Lilly	USD 62.07B	12.22B	2025-09
Esperion Therapeutics	USD 360.46M	17.87M	2025-09
Exelixis	USD 1.4B	221.5M	2025-09
Gilead Sciences	USD 18.84B	4.12B	2025-09
GlaxoSmithKline	GBP 17.51B	332M	2025-12
Grifols	EUR 6.28B	92.48M	2025-09
Halozyme Therapeutics	USD 1.33B	206.08M	2025-09
Incyte	USD 5.02B	746.01M	2025-12
Ionis Pharmaceuticals	USD 2.52B	58.16M	2025-09
Ironwood Pharmaceuticals	USD 273.84M	82.09M	2025-09
Karyopharm Therapeutics	USD 89.75M	8.12M	2025-09
MacroGenics	USD 232.09M	27.15M	2025-09
Merck	USD 47.56B	10.49B	2025-09
Nektar Therapeutics	USD 281.36M	94.79M	2025-09
Neurocrine Biosciences	USD 2.16B	409.5M	2025-09
Novartis	USD 28.2B	2.26B	2025-09
Pfizer	USD 46.92B	3.22B	2025-09
Roche Holding	CHF 38.73B	3.03B	2025-12
Sarepta Therapeutics	USD 2.72B	65.32M	2025-09
Takeda	JPY 3.12T	195.82B	2025-12
Teva Pharmaceutical Industries	USD 13.95B	1.21B	2025-12
Xencor	USD 518.44M	5.29M	2025-09

Nektar Therapeutics Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.